chf 215.65 <%= Resources.Global.txtDown %>
Updated 20/04/2018
Change % -0.39% Stock price decreasing
Change -0.85 Stock price decreasing
Volume 1,753,859
High CHF 217.25
Low CHF 215.40
Open CHF 216.00
ISIN CH0012032048
Prev close CHF 216.50
# of shares 702.56M
Market cap 151,508M CHF
Intraday

Market closed
Roche GS
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  215.65 -0.7% Stock price decreasing -1.6% Stock price decreasing -8.0% Stock price decreasing -8.0% Stock price decreasing -14.3% Stock price decreasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 59.19 1.2% Stock price increasing -5.2% Stock price decreasing -0.2% Stock price decreasing 5.1% Stock price increasing 36.0% Stock price increasing 3.7% Stock price increasing
 
Bristol-Myers Squibb Company 51.17 -12.8% Stock price decreasing -22.6% Stock price decreasing -17.8% Stock price decreasing -20.6% Stock price decreasing -4.3% Stock price decreasing -16.5% Stock price decreasing
 
Eli Lilly and Company 79.06 -0.8% Stock price decreasing 1.0% Stock price increasing -7.5% Stock price decreasing -9.4% Stock price decreasing -3.5% Stock price decreasing -6.4% Stock price decreasing
 
Merck & Company Inc (new) 58.83 2.9% Stock price increasing 7.6% Stock price increasing -4.0% Stock price decreasing -7.9% Stock price decreasing -4.9% Stock price decreasing 4.5% Stock price increasing
 
Pfizer Inc 36.63 0.9% Stock price increasing 1.0% Stock price increasing -0.8% Stock price decreasing 0.6% Stock price increasing 8.9% Stock price increasing 1.1% Stock price increasing
 
Astrazeneca PLC ORD SHS $0.25 4,971.05 -0.8% Stock price decreasing 2.3% Stock price increasing -1.4% Stock price decreasing -3.7% Stock price decreasing 8.9% Stock price increasing -2.9% Stock price decreasing
 
Novartis NAM SF 0,50 63.80 -2.8% Stock price decreasing -3.8% Stock price decreasing -10.2% Stock price decreasing -12.3% Stock price decreasing -7.2% Stock price decreasing -9.7% Stock price decreasing
 
Glaxosmithkline PLC ORD 25P 1,428.36 0.6% Stock price increasing 10.2% Stock price increasing 5.2% Stock price increasing -6.2% Stock price decreasing -8.8% Stock price decreasing 8.0% Stock price increasing
 
Sanofi 65.28 -1.1% Stock price decreasing 0.4% Stock price increasing -10.5% Stock price decreasing -22.1% Stock price decreasing -20.7% Stock price decreasing -9.1% Stock price decreasing

Company profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for more than 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.

Peers

Instruments Last Change  
Abbott Labor.. 59.19 -1.2% Stock price decreasing
Bristol-Myer.. 51.17 -0.9% Stock price decreasing
Eli Lilly an.. 79.06 -0.9% Stock price decreasing
Merck & Comp.. 58.83 0.3% Stock price increasing
Pfizer Inc 36.63 0.3% Stock price increasing
Astrazeneca .. 4,971.05 0.3% Stock price increasing
Novartis NAM.. 63.80 -0.9% Stock price decreasing
Glaxosmithkl.. 1,428.36 1.5% Stock price increasing
Sanofi 65.28 -0.5% Stock price decreasing

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 April 2018 18:08:31
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180417.1 - EUROWEB6 - 2018-04-21 19:08:31 - 2018-04-21 18:08:31 - 1000 - Website: OKAY